{
  "hypotheses": [
    {
      "id": "H1",
      "prediction": "IF isolated mitoplasts (OMM-stripped) are exposed to Ca\u00b2\u207a (200 \u00b5M) + Pi (2 mM), THEN CsA-sensitive \u0394\u03a8m collapse occurs with identical EC\u2085\u2080 (\u00b115%) compared to intact mitochondria, AND pre-treatment of intact mitochondria with VBIT-4 (20 \u00b5M) blocks VDAC1 oligomerization (>80% reduction by crosslinking/native PAGE) without preventing initial mPTP-driven \u0394\u03a8m loss (\u226420% delay in onset).",
      "source_claims": [],
      "key_variables": [],
      "parameters": [
        {
          "name": "4_IC50_oligomerization",
          "unit": "\u00b5M",
          "low": 1.0,
          "high": 50.0,
          "distribution": "uniform",
          "mean": null,
          "std": null
        },
        {
          "name": "CsA_concentration",
          "unit": "\u00b5M",
          "low": 0.5,
          "high": 2.0,
          "distribution": "uniform",
          "mean": null,
          "std": null
        },
        {
          "name": "mPTP_onset_delay_with_VBIT4",
          "unit": "s",
          "low": 0.0,
          "high": 60.0,
          "distribution": "uniform",
          "mean": null,
          "std": null
        },
        {
          "name": "VDAC1_oligomer_reduction",
          "unit": "%",
          "low": 50.0,
          "high": 100.0,
          "distribution": "uniform",
          "mean": null,
          "std": null
        }
      ],
      "testability_score": 8.0,
      "experimental_protocol": "Isolate liver mitochondria (mouse) and prepare mitoplasts by digitonin titration (0.1 mg/mg protein). Load with TMRM (100 nM) and Fluo-4 AM. Challenge with Ca\u00b2\u207a pulses (50-500 \u00b5M) \u00b1 CsA (1 \u00b5M) \u00b1 VBIT-4 (5, 10, 20 \u00b5M). Monitor \u0394\u03a8m by plate reader kinetics (1-s resolution, 30 min). At defined timepoints, crosslink with EGS (0.5 mM, 15 min) and run native PAGE/Western for VDAC1 oligomers. Compare intact mitochondria vs. mitoplasts.",
      "expected_outcome": "mPTP opens in mitoplasts lacking OMM/VDAC1; VBIT-4 blocks oligomerization but \u0394\u03a8m collapse onset is unchanged; CsA blocks both. Oligomerization appears 2-5 min after* initial \u0394\u03a8m drop.",
      "null_outcome": "VBIT-4 prevents or delays mPTP opening itself (>50% increase in calcium retention capacity), OR mitoplasts fail to show CsA-sensitive PT, indicating VDAC1 is required for initiation.",
      "dose_ranges": {
        "4": {
          "doses": [
            5.0,
            10.0,
            20.0
          ],
          "unit": "\u00b5M;"
        },
        "CsA": {
          "doses": [
            0.5,
            1.0,
            2.0
          ],
          "unit": "\u00b5M"
        }
      },
      "readouts": [
        "TMRM fluorescence (\u0394\u03a8m kinetics)",
        "Fluo-4 (matrix Ca\u00b2\u207a)",
        "native PAGE + anti-VDAC1 Western (oligomer quantification)",
        "light scattering at 540 nm (swelling)"
      ],
      "controls": [
        "Vehicle (DMSO)",
        "CsA alone",
        "VBIT-4 alone",
        "Ca\u00b2\u207a-free",
        "alamethicin (maximal swelling)",
        "digitonin titration verification by citrate synthase accessibility",
        "---",
        "##"
      ]
    },
    {
      "id": "H2",
      "prediction": "IF mitochondria from mouse heart, brain cortex, and liver are subjected to sequential Ca\u00b2\u207a boluses (10 \u00b5M increments), THEN calcium retention capacity (CRC) before irreversible \u0394\u03a8m collapse follows: cardiac < neuronal < hepatic, with CRC values of 150-250, 250-400, and 400-700 nmol Ca\u00b2\u207a/mg protein respectively, AND the Ca\u00b2\u207a load at which VDAC1 oligomers first appear (by crosslinking) correlates with CRC (r\u00b2 > 0.7).",
      "source_claims": [],
      "key_variables": [],
      "parameters": [
        {
          "name": "CRC_cardiac",
          "unit": "nmol/mg",
          "low": 100.0,
          "high": 300.0,
          "distribution": "uniform",
          "mean": null,
          "std": null
        },
        {
          "name": "CRC_neuronal",
          "unit": "nmol/mg",
          "low": 200.0,
          "high": 500.0,
          "distribution": "uniform",
          "mean": null,
          "std": null
        },
        {
          "name": "CRC_hepatic",
          "unit": "nmol/mg",
          "low": 300.0,
          "high": 800.0,
          "distribution": "uniform",
          "mean": null,
          "std": null
        },
        {
          "name": "Cardiolipin_content",
          "unit": "nmol/mg",
          "low": 5.0,
          "high": 25.0,
          "distribution": "uniform",
          "mean": null,
          "std": null
        }
      ],
      "testability_score": 9.0,
      "experimental_protocol": "Isolate mitochondria from 8-week C57BL/6 mouse heart (Percoll gradient), cortical brain (ficoll), and liver (differential centrifugation), n=6 per tissue. Perform CRC assay with Calcium Green-5N (1 \u00b5M) in standard respiration buffer (125 mM KCl, 2 mM KH\u2082PO\u2084, 5 mM glutamate/malate), adding 10 \u00b5M Ca\u00b2\u207a pulses every 60 s. At each pulse, remove aliquot for EGS crosslinking + VDAC1 native PAGE. Quantify CypD by Western blot and cardiolipin by LC-MS/MS. Repeat \u00b1 CsA (1 \u00b5M) and \u00b1 VBIT-4 (20 \u00b5M).",
      "expected_outcome": "Cardiac mitochondria show lowest CRC, earliest VDAC1 oligomerization; hepatic highest CRC, latest oligomerization. CypD/ANT ratio inversely correlates with CRC. CsA equalizes CRC across tissues (\u00b130%). VBIT-4 does not change CRC but delays oligomer appearance.",
      "null_outcome": "CRC values are statistically indistinguishable across tissues (ANOVA p>0.05), OR ranking differs from predicted (e.g., neuronal most resistant), OR VDAC1 oligomerization timing does not correlate with CRC.",
      "dose_ranges": {
        "pulses": {
          "doses": [
            10.0
          ],
          "unit": "\u00b5M"
        },
        "CsA": {
          "doses": [
            0.5,
            1.0,
            2.0
          ],
          "unit": "\u00b5M;"
        },
        "4": {
          "doses": [
            10.0,
            20.0
          ],
          "unit": "\u00b5M"
        }
      },
      "readouts": [
        "Calcium Green-5N fluorescence (CRC)",
        "TMRM (\u0394\u03a8m)",
        "native PAGE/Western (VDAC1 oligomers)",
        "Western blot (CypD",
        "ANT",
        "ATP synthase subunit c)",
        "LC-MS/MS (cardiolipin species)",
        "citrate synthase activity (normalization)"
      ],
      "controls": [
        "Alamethicin (max swelling)",
        "EGTA (Ca\u00b2\u207a chelation)",
        "CypD-KO mouse mitochondria (positive control for CsA-insensitive component)",
        "boiled mitochondria (negative)",
        "---",
        "##"
      ]
    },
    {
      "id": "H3",
      "prediction": "IF VDAC1 is genetically ablated (CRISPR triple-KO of VDAC1/2/3) in HeLa or MEF cells, THEN Ca\u00b2\u207a overload (ionomycin 5 \u00b5M + thapsigargin 2 \u00b5M) still triggers mPTP opening (CsA-sensitive \u0394\u03a8m loss), BUT death shifts from necrosis (>70% PI+/AnnexinV+ in WT) to apoptosis (>60% AnnexinV+/PI\u2212 in KO), with reduced LDH release (>50% reduction), maintained caspase-3 activation, and absence of mitochondrial swelling.",
      "source_claims": [],
      "key_variables": [],
      "parameters": [
        {
          "name": "Necrosis_fraction_WT",
          "unit": "%",
          "low": 50.0,
          "high": 90.0,
          "distribution": "uniform",
          "mean": null,
          "std": null
        },
        {
          "name": "Apoptosis_fraction_KO",
          "unit": "%",
          "low": 40.0,
          "high": 80.0,
          "distribution": "uniform",
          "mean": null,
          "std": null
        },
        {
          "name": "LDH_release_reduction_KO",
          "unit": "%",
          "low": 30.0,
          "high": 80.0,
          "distribution": "uniform",
          "mean": null,
          "std": null
        },
        {
          "name": "Caspase3_activity_KO_vs_WT",
          "unit": "fold",
          "low": 1.0,
          "high": 3.0,
          "distribution": "log-normal",
          "mean": null,
          "std": null
        },
        {
          "name": "mPTP_opening_delay_KO",
          "unit": "min",
          "low": 0.0,
          "high": 30.0,
          "distribution": "uniform",
          "mean": null,
          "std": null
        }
      ],
      "testability_score": 7.0,
      "experimental_protocol": "Generate VDAC1/2/3 triple-KO HeLa cells via sequential CRISPR-Cas9 (validated by Western blot and functional reconstitution). Treat WT and KO with ionomycin (2, 5, 10 \u00b5M) \u00b1 CsA (1 \u00b5M) or VBIT-4 (20 \u00b5M) for 2-8 h. Assess: (1) \u0394\u03a8m by TMRM live imaging, (2) death mode by AnnexinV-FITC/PI flow cytometry at 2, 4, 8 h, (3) LDH release (supernatant), (4) caspase-3/7 activity (luminescent assay), (5) mitochondrial swelling by TEM, (6) cytochrome c release by digitonin fractionation/Western. Include Bax/Bak DKO as apoptosis-",
      "expected_outcome": "VDAC-KO cells still undergo CsA-sensitive \u0394\u03a8m loss but die primarily by apoptosis (caspase-dependent, AnnexinV+/PI\u2212, minimal swelling). WT cells show necrosis (PI+, LDH high, swollen mitochondria). CsA blocks both. VBIT-4 phenocopies KO in WT cells.",
      "null_outcome": "VDAC-KO cells show identical necrotic death kinetics and markers as WT (death mode independent of VDAC), OR VDAC-KO cells are completely resistant to Ca\u00b2\u207a-induced death (VDAC required for mPTP itself).",
      "dose_ranges": {
        "Ionomycin": {
          "doses": [
            2.0,
            5.0,
            10.0
          ],
          "unit": "\u00b5M;"
        },
        "Thapsigargin": {
          "doses": [
            1.0,
            2.0,
            5.0
          ],
          "unit": "\u00b5M;"
        },
        "CsA": {
          "doses": [
            0.5,
            1.0,
            2.0
          ],
          "unit": "\u00b5M;"
        },
        "4": {
          "doses": [
            5.0,
            10.0,
            20.0
          ],
          "unit": "\u00b5M;"
        },
        "FMK": {
          "doses": [
            20.0,
            50.0
          ],
          "unit": "\u00b5M"
        }
      },
      "readouts": [
        "Flow cytometry (AnnexinV/PI)",
        "TMRM fluorescence",
        "LDH assay",
        "Caspase-Glo 3/7",
        "TEM (cristae/swelling morphometry)",
        "Western (cytochrome c",
        "cleaved PARP",
        "VDAC1)"
      ],
      "controls": [
        "WT + DMSO",
        "WT + CsA",
        "WT + VBIT-4",
        "VDAC-KO + CsA",
        "Bax/Bak DKO (apoptosis block)",
        "z-VAD-FMK (caspase inhibition to test necrosis default)",
        "staurosporine (canonical apoptosis control)",
        "---",
        "##"
      ]
    },
    {
      "id": "H4",
      "prediction": "IF proximity ligation assay (PLA) or FRET is performed on intact energized mitochondria during",
      "source_claims": [],
      "key_variables": [],
      "parameters": [],
      "testability_score": 5.0,
      "experimental_protocol": "",
      "expected_outcome": "",
      "null_outcome": "",
      "dose_ranges": {},
      "readouts": [],
      "controls": []
    }
  ],
  "n_hypotheses": 4,
  "total_calls": 1,
  "latency_s": 54.98
}